Introduction {#S1}
============

Psoriasis is a chronic inflammatory skin disease affecting approximately 2% of the population ([@B57]) and characterized by cutaneous lesions that may appear on any part of the body. This condition can be very challenging and has such a strong impact on patients' physical appearance in that embarrassment over appearance is rated as the most debilitating feature of the disease ([@B67]). Psychological stress, in turn, has a negative impact on psoriasis symptoms leading to a self-perpetuating mechanism that might be difficult to interrupt ([@B4]). In such a scenario, emotional reactivity (i.e., the emotional response provoked by the perception and the valuation of a given situation; [@B18]) and emotion regulation (i.e., the ability to modify the perceived emotion in terms of its quality, intensity, or duration; [@B18]) become particularly crucial. Importantly, the way in which we experience and regulate our emotions is strictly dependent on the ability to recognize and distinguish them from other bodily sensations ([@B6]), thus, deficit in such domain (i.e., alexithymia) can also worsen the affective experience of psoriasis patients.

In what follows, we provide a review of the literature tapping into emotional processing in psoriasis with the aim of characterizing it in terms of emotional reactivity, alexithymia, and emotion regulation. Even though these constructs can be correlated with each other, here, we highlight how their abnormal functioning is associated with different dermatological, psychological, or life quality outcomes. Finally, we discuss the implications for clinical practice and research.

Methods {#S2}
=======

We conducted a search of PubMed's database of articles containing the word "psoriasis" and one of the following terms: emotional reactivity, alexithymia, social exclusion, stigmatization, stress, anxiety, depression, and emotion regulation. Additional records were identified through manual searches of references of identified articles. Thirty-seven studies were selected (see [Table 1](#T1){ref-type="table"}).

###### 

Description of the studies identified by the review.

  **N**   **Authors Year**   **Type of study**           **Number of patients**                 **Number of control participants**                         **Emotional reactivity/regulation/alexithymia/stress**   **Measures behavioral/self-report**   **Outcome**
  ------- ------------------ --------------------------- -------------------------------------- ---------------------------------------------------------- -------------------------------------------------------- ------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1       [@B5]              Cross-sectional             105                                    Absent                                                     Emo                                                      Self-report                           High prevalence of anxiety
  2       [@B50]             Longitudinal (2 sessions)   164                                    Absent                                                     Emo                                                      Self-report                           Anxiety is higher in women and correlates with the severity of the disease
  3       [@B22]             Cross-sectional             50                                     50                                                         Emo                                                      Self-report                           Higher anxiety and depression than controls
  4       [@B67]             Cross-sectional             100                                    100                                                        Emo                                                      Self-report                           In psoriasis, the relationship between disease severity and quality of life is mediated by the feeling of stigmatization
  5       [@B31]             Cross-sectional             148                                    Absent                                                     Emo                                                      Self-report                           Stigmatization seems to be the most powerful predictor of depressive symptoms in these patients
  6       [@B53]             Cross-sectional             115                                    Absent                                                     Emo                                                      Self-report                           Stigmatization is related to psychological distress and degree of disability
  7       [@B15]             Cross-sectional             100                                    Absent                                                     Emo                                                      Self-report                           Stigmatization is higher when psoriasis has an early onset and the extent of bleeding is wider and feeling of rejection is stronger
  8       [@B16]             Cross-sectional             100                                    Absent                                                     Emo                                                      Self-report                           Stigmatization interferes with work and daily activities
  9       [@B65]             Cross-sectional             514                                    Absent                                                     Emo                                                      Self-report                           Stigmatization was associated with higher impact on daily life; lower education; higher disease visibility, severity, and duration; higher levels of social inhibition; having a type D personality; and not having a partner
  10      [@B20]             Cross-sectional             102                                    Absent                                                     Emo                                                      Self-report                           Stigmatization is assiciated with: pruritus intensity, stress, depressive symptoms and lower quality of life
  11      [@B49]             Cross-sectional             16                                     17                                                         Emo ER                                                   Behavioral and physiological          Higher sympathetic activity during social exclusion which brings to higher need for social reconnection
  12      [@B30]             Cross-sectional             171                                    171                                                        Emo                                                      Self-report                           Shame and disgust correlated with a less positive evaluation of being touched by their parents when they were kids
  13      [@B64]             Cross-sectional             50 + 50 (significant ones psoriasis)   50 (alopecia) 50 (significant ones alopecia) 50 controls   Emo                                                      Behavioral                            Patients with psoriasis and their significant ones avoid disgusted faces more than controls
  14      [@B55]             Cross-sectional             936                                    Absent                                                     Emo                                                      Self-report                           Shame is higher in women than men. Shame and anger are more frequent in patients with low level of education
  15      [@B24]             Cross-sectional             42511                                  Reference population: 4724748                              Emo                                                      Clinical diagnosis                    Developing depression after psoriasis is mediated by the presence of other comorbidities
  16      [@B69]             Cross-sectional             219                                    Absent                                                     Emo                                                      Self-report                           Depression is predicted by: psychological distress, negative beliefs about one's own appearance, and lower levels of emotional and social support
  17      [@B48]             Cross-sectional             112                                    77 (melanoma) 53 (allergy)                                 Emo                                                      Self-report                           Psoriasis is more frequently associated with suicidal ideation and attempt
  18      [@B2]              Cross-sectional             85                                     86 (healthy)                                               Emo                                                      Self-report                           Higher anger related to lower self-esteem
  19      [@B39]             Cross-sectional             38                                     113 (depression) 32 (healthy)                              Emo                                                      Self-report                           High in outward aggression and low in autoaggression
  20      [@B47]             Cross-sectional             40                                     116 (other dermatological)                                 Alexi                                                    Self-report                           Higher alexithymia
  21      [@B21]             Cross-sectional             100                                    97 (healthy)                                               Emo Alexi                                                Self-report                           The effect of psoriasis on quality of life is mediated by difficulties in emotion regulation, anxiety, depression, and food craving Higher alexithymia
  22      [@B60]             Cross-sectional             250                                    215 (healthy)                                              Alexi                                                    Self-report                           Higher alexithymia Association between alexitimia and female gender and involvment of sensitive body areas
  23      [@B28]             Cross-sectional             100                                    100 (healthy)                                              Emo Alexi                                                Self-report                           Higher alexithymia
  24      [@B29]             Cross-sectional             108                                    Absent                                                     Emo Alexi                                                Self-report                           Psoriasis with alexithymia is related to higher somatization, interpersonal sensitivity, anxiety, and phobic anxiety than Psoriasis witout alexithymia
  25      [@B10]             Longitudinal                92                                     Absent                                                     Alexi                                                    Self-report                           Patients with low emotional awareness are more reactive to stress and more responsive to treatment
  26      [@B68]             Cross-sectional             33                                     33 (healthy)                                               ER                                                       Self-report                           Higher use of emotion supression
  27      [@B8]              Cross-sectional             91                                     101 (healthy)                                              ER                                                       Self-report                           Higher use of emotion supression More impulse control difficulties, and non-acceptance of emotional responses
  28      [@B7]              Cross-sectional             23                                     18 (dermatological) 27 (healthy)                           ER                                                       Self-report                           Suppression is negatively related with quality of life, while reappraisal is positively related with patients well being
  29      [@B1]              Cross-sectional             228                                    Absent                                                     ER                                                       Self-report                           Higher difficulties in ER negatively correlates with treatment satisfaction and positively correlates with: discomfort due to the disease; psychopathological symptoms; missed work/school days
  30      [@B46]             Cross-sectional             33                                     73 (dermatological)                                        Alexi ER                                                 Self-report                           More likely to have alexithymia. Lower perceived social support and higher insicure attachment
  31      [@B33]             Longitudinal                163                                    Absent                                                     Alexi ER                                                 Self-report                           Lower self-management is associated with higher alexithymia
  32      [@B38]             Cross-sectional             25                                     50                                                         ER                                                       Behavioral                            Higher increase of heart rate and diastolic blood pressure during stress induction
  33      [@B37]             Cross-sectional             25                                     50                                                         ER                                                       Behavioral                            No change in cortisol levels and stress perception after stress induction
  34      [@B44]             Cross-sectional             16                                     17                                                         ER                                                       Behavioral                            Patients perform better and show reduced sympathetic system activity when the cognitive load associated to the emotional task is high
  35      [@B25]             Cross-sectional             10                                     10 (acne) 10 (melanoma)                                    Stress                                                   Self-report                           More sensitive to stress
  36      [@B59]             Cross-sectional             45                                     191 (dermatologic)                                         Stress                                                   Self-report                           Psoriatic arthritis report less positive and more negative (stressful) life events during late childhood
  37      [@B42]             Cross-sectional             141                                    Absent                                                     Stress                                                   Self-report                           Perceived stress is associated with a poorer level of quality of life, higher levels of anxiety and depression

Emotional Reactivity {#S3}
====================

Emotional reactivity is the constellation of behavioral and physiological changes triggered by the evaluation of a given situation in relation to one's own active goals ([@B18]). It can assume the form of a discrete emotion (i.e., an intense and short-lived response; [@B56]) or a feeling (i.e., the conscious experience of the emotion state; [@B62]), or it can be chronically altered in affective clinical disorders (i.e., fear in anxiety or sadness in depression). Pathological forms of emotional reactivity are typically characterized in terms of *emotion intensity* (e.g., emotional hyporeactivity), *emotion duration* (e.g., prolonged negative emotions), *emotion frequency* (e.g., frequent aggressive episodes), or *emotion type* (e.g., displaying inappropriate emotions) ([@B18]). Psoriasis patients tend to experience a wide range of negative emotions that can be altered in several of these qualities ([@B55]). Below, we provide a detailed review of emotions (anger, disgust, and shame), feelings (stigmatization and social exclusion), and affective clinical disorders (anxiety and depression) that have been studied in relation to psoriasis.

Anxiety {#S3.SS1}
-------

Psoriasis is characterized by anxiety (i.e., the feeling of apprehension, uncertainty, and fear) as showed by the high prevalence of anxiety disorders (13.1%; [@B32]) diagnosed in these patients ([@B5]; [@B14]). Self-reported anxiety seems to be higher in women with psoriasis with respect to men and is positively correlated with the severity of the disease ([@B50]). Recently, higher level of anxiety and depression has been found in these patients, even in a sample of psoriasis patients with cognitive deficits ([@B22]).

Stigmatization, Shame, and Disgust {#S3.SS2}
----------------------------------

Given its impact on patients' physical appearance, psoriasis is often associated with a feeling of stigmatization, especially when it appears early in patients' life ([@B57]). Stigmatization is higher when the disease has an early onset and when the extent of bleeding and feeling of rejection are greater ([@B15]). It has been shown that high levels of stigmatization are caused by disease's severity and, in turn, provoke a significant decrement of quality of life ([@B67]). Moreover, stigmatization seems to (i) be the most powerful predictor of depressive symptoms in these patients ([@B20]; [@B31]); (ii) be significantly related to psychological distress and degree of disability ([@B53]); and (iii) interfere with work and daily activities ([@B16]). Patients suffering from stigmatization tend not to have a partner, to have lower education, to have a higher level of social inhibition, to show a type D personality ([@B65]), to have higher stress and pruritus intensity, and to have lower quality of life ([@B20]). In a recent study ([@B49]), we showed that in patients with psoriasis with respect to controls, higher sympathetic system activation during an experimental paradigm designed to induce the feeling of social exclusion (i.e., cyberball paradigm) was related to a higher need for social reconnection (i.e., the need to invest in new social interactions).

When chronic stigmatization is associated with an anxious ambivalent attachment style, dermatological patients' view of themselves can be severely influenced, and they can manifest negative feelings of self-disgust ([@B23]). Psoriasis patients show higher sense of skin-related shame and disgust, which correlates with a less positive evaluation of being touched by their parents when they were kids ([@B30]). Interestingly, it has been shown that not only psoriasis patients but also their significant ones tend to avoid disgusted faces more than do controls ([@B64]). Shame---which is associated with the severity of psoriasis symptoms and also with depression and anxiety---seems to be higher in women than men, and it is more frequent in patients with a low level of education ([@B55]).

Depression {#S3.SS3}
----------

It has been shown that the risk of developing depression in psoriasis patients (prevalence of 9.9% of Major Depressive Disorder; [@B32]) seems to be mediated by the presence of other comorbidities, except in younger patients with severe psoriasis where the presence of the disease directly predicts the onset of depression ([@B24]). Psychological distress, negative beliefs about one's own appearance, and lower levels of emotional and social support are factors that predispose to the development of depression in psoriasis ([@B69]). Also, compared with patients with other dermatological conditions such as acne or alopecia areata, psoriasis patients show higher scores of depression, and suicidal ideation ([@B48]).

Anger {#S3.SS4}
-----

It has been shown that in dermatologic conditions, aggression is associated with anxiety, and with a lower level of optimism and social support ([@B9]). In psoriasis, anger (subclinical condition) frequency correlates with severity and length of the disease, and it is higher in patients with a low level of education ([@B55]). Psoriasis patients are characterized by a higher level of trait anger respect to controls; moreover, when they have low self-esteem, they show more anger toward people or objects and have enhanced difficulties in anger control ([@B2]); conversely, they score very low in autoaggression ([@B39]). Notably, however, one study reported that psoriasis patients exhibited fewer verbal aggression responses after anger-inducing procedures ([@B41]).

Alexithymia {#S4}
===========

Alexithymia is a subclinical trait defined by difficulties in the following: (i) identifying, describing, and communicating one's own feelings; (ii) differentiating them from emotionally unrelated bodily sensations; (iii) emotional awareness related to psychosomatic symptoms; and (iv) imagination, daydreaming, and introspection ([@B36]; [@B61]). Crucially, identifying emotions is believed to be related to the ability to regulate them ([@B6]).

Neuroscientific evidence links alexithymia to (i) aberrant emotion processing (i.e., decreased activation of limbic structures in response to negative emotional stimuli and angry vs. neutral faces; [@B26]; [@B66]; (ii) reduced gray matter volume in emotional processing brain areas ([@B70]); and (iii) reduced connectivity within the default mode network (DMN), in brain areas involved in emotional awareness and increased connectivity of the DMN with areas involved in sensory input and emotion control ([@B34]).

The association between alexithymia and various medical disorders suggests that it may represent a risk factor for their development, probably because it enhances stress responses through autonomic dysregulation (i.e., the alexithymia--stress hypothesis; [@B36]). In particular, alexithymic people seem not to cope effectively with stressors because of a stress response that is typically altered in its cognitive (i.e., lack of emotional awareness), behavioral (i.e., maladaptive coping and lack of emotional expression), and physiological (i.e., increased arousal) components ([@B36]). This altered response to stress might prolong the exposure to stressors and, on the long run, exacerbate the somatovisceral response ([@B36]).

Also, alexithymia presents hypo-reactive physiological responses rather than hyper-reactive ones ([@B66]) and seems to be associated with poorer interoception and the tendency to misattribute bodily signals ([@B43]). Misinterpretation of bodily sensations associated with negative emotions might be another mechanism through which alexithymia worsens clinical conditions ([@B35]; [@B63]).

Alexithymia is often associated with psoriasis ([@B47], [@B46]; [@B21]) (prevalence of 24.8%, [@B54]), especially in women and in cases in which the plaques extend to sensitive body areas (like the face, the hands, or the genitals) ([@B60]). These patients show a higher level of somatization, interpersonal sensitivity, anxiety, and phobic anxiety respect to non-alexithymic patients ([@B28], [@B29]). Some researchers suggested that alexithymia might be a condition that patients acquired in order to avoid dealing with unwanted emotions ([@B45]). Consistently with this point of view, emotional awareness, an emotional skill distinct but often correlated to alexithymia, consisting in the ability to integrate and differentiate emotions, predicts better response to treatment in psoriasis patients ([@B10]). The reported studies measured alexithymia using the Toronto Alexithymia Scale (TAS−20; [@B3]).

Emotion Regulation {#S5}
==================

Emotion regulation is a multi-componential process that comprehends the implicit and explicit strategies through which we act on the emotional experience in order to enhance or reduce it ([@B19]). Maladaptive emotion regulation is a component of many psychopathological diseases such as depression ([@B12]) and post-traumatic stress disorder ([@B40]).

Compared with controls, patients with psoriasis are characterized by higher use of emotional suppression ([@B68]; [@B7], [@B8]), an emotion regulation strategy considered rather primitive that consists in inhibiting the expression of the ongoing emotional response once it has been generated ([@B19]). Interestingly, this is the same strategy used by recovered-depressed patients ([@B12]). Conversely, higher use of reappraisal ([@B7]), an emotion regulation strategy that is more adaptive than suppression and consists in re-thinking the situation to alter its meaning and emotional impact ([@B19]), has shown to be positively related with patients' well-being ([@B7]). In patients with psoriasis, higher difficulty in emotion regulation, as measured by the difficulty in emotion regulation strategies (DERS) scale, negatively correlates with treatment satisfaction and positively correlates with (i) the discomfort due to the disease; (ii) the number of reported psychopathological symptoms; and (iii) the frequency of missed work/school days ([@B1]). Moreover, subtypes of psoriasis patients also show different patterns of emotion regulation: early-diagnosed patients have higher difficulties in behaving according to their goals when distressed ([@B1]); obese patients with psoriasis show higher difficulties respect to obese patients without psoriasis ([@B21]). It has also been shown that the ability of impulse control (subclinical condition) when experiencing negative emotions is lower in this condition ([@B21]). Two subscales of the DERS, namely, emotional clarity and emotion acceptance, which are believed to measure concepts that are very close to alexithymia, also show higher scores among these patients ([@B21]). In agreement, in two recent studies, we showed that psoriasis patients scored higher than controls in the "Lack of Emotional Clarity" subscale of the DERS, indicating that patients have more difficulties than controls in correctly identifying their own emotions ([@B44]; [@B49]).

It has been hypothesized that low abilities in emotion regulation in psoriasis patients might increase the impact of poor social support on the severity of the disease ([@B46]). Moreover, lower self-management, a psychological construct composed of medical management, role management, and emotional management, is associated with higher alexithymia in patients with moderate to severe psoriasis ([@B33]).

It has to be noticed that most of the studies present in the scientific literature, at least to our knowledge, employed self-report measures or questionnaires. The lack of behavioral and physiological evidence regarding emotion regulation deficits in this population is crucial. Two studies reported some indirect measure by submitting patients to a standardized stressful procedure (mental arithmetic and the Stroop Color-Word Naming Test). They found higher heart rate and diastolic blood pressure in psoriasis patients ([@B38]), which, however, was not accompanied by differences in stress perception or salivary cortisol levels ([@B37]). Importantly, we recently showed that when presented with a working memory task with emotional distractors (i.e., the Emotional N-Back), psoriasis patients perform better and show reduced sympathetic system activity when the cognitive load associated with the task is high versus low and thus found it easier not to pay attention to the emotional distractors ([@B44]).

To sum up, the impact of emotion regulation abilities on the course of psoriasis seems crucial: patients' well-being is negatively associated with suppression and is positively associated with reappraisal. Suppression and rumination are indeed more strongly linked to psychopathological outcomes than reappraisal and acceptance strategies ([@B27]). To our knowledge, there are no studies exploring the employment of acceptance strategies in psoriasis.

Stress Managing {#S5.SS1}
---------------

The experience of stress can impact each of the three aspects of emotional processing that we mentioned in this review (i.e., emotional reactivity, alexithymia, and emotion regulation): (i) exposure to stressors is correlated to higher experience of negative emotions ([@B13]); (ii) higher basal cortisol level during stress anticipation is associated with higher alexithymia ([@B11]); and (iii) acute stress impairs emotion regulation during fear conditioning ([@B51]).

Stress managing is pivotal in psoriasis patients because impaired emotional processing could affect not only the response to stressful events but also the quality of the general emotional response in psoriasis. Patients with psoriasis are more sensitive to stress with respect to other dermatological conditions such as acne or melanoma ([@B25]), and patients with psoriatic arthritis report less positive and more negative (stressful) life events during late childhood ([@B59]). Stressful events are indeed very often reported by patients as the cause of the appearance or the exacerbation of the disease ([@B17]). Perceived stress in patients is significantly associated with a poorer level of quality of life and higher levels of depression and anxiety ([@B42]) and might be associated with dermatological worsening of the plaques ([@B4]).

Conclusion and Future Directions {#S6}
================================

From our review, it is apparent that emotional reactivity, alexithymia, and emotion regulation have a profound impact on the management of psoriasis symptoms. On the one hand, emotional reactivity in patients with psoriasis seems to be characterized by negative emotions such as anger ([@B39]; [@B55]; [@B2]), shame ([@B55]; [@B58]; [@B30]), disgust ([@B30]), and feelings like social exclusion ([@B67]; [@B57]; [@B30]; [@B65]; [@B31]) and also by psychopathological disorders such as anxiety ([@B50]; [@B5]; [@B14]) and depression ([@B24]). This emotional pattern seems to affect slightly more women ([@B55]; [@B50]; [@B60]) than men and to be a risk factor for a wide range of negative outcomes spanning from lower quality of life ([@B67]; [@B42]; [@B68]) to suicide ([@B48]).

On the other hand, the ability to regulate emotions seems to be a protective factor that improves quality of life ([@B68]), treatment satisfaction, and the impact of negative emotions ([@B1]). This is especially true when patients do not suffer from alexithymia. The effect of presence of alexithymia or low emotional awareness in these patients is not completely clear: on the one hand, it seems to help them in ignoring unwanted emotions ([@B45]) and improve the treatment outcome ([@B10]); on the other hand, it seems to worsen the impact of emotions on quality of life ([@B46]; [@B1]). From this literature review, it appears clear that treatments for psoriasis should also include techniques that address emotional reactivity, alexithymia, and emotion regulation because affective symptoms, together with dermatological ones, play a fundamental role in the resolution of this condition. One promising candidate would be the emotion regulation therapy (ERT), which is a manualized intervention that aims at (i) increasing emotional and motivational awareness; (ii) developing emotion regulation abilities; and (iii) generating new learning experiences ([@B52]).

Our review also highlights some limitations of the approaches that have been used so far for studying emotional processes in psoriasis. First of all, only few studies ([@B38], [@B37]; [@B64]; [@B44]; [@B49]) reported behavioral and physiological evidence. Although we acknowledge that self-report measures are important to understand the conscious evaluation that patients have of themselves, we also believe that implicit measures are crucial to understand what are the abilities that are truly compromised in these patients. Future studies should include these measurements and compare them with self-report measures in order to obtain a fine-grained picture of emotional processing in these patients. Second, many studies (15 of the 37 we reviewed) did not test a control group; this practice does not allow to disentangle whether what is observed is specific of this skin condition or is also true in the general population. Furthermore, very few studies tested a clinical control group with other dermatological conditions. Including such control groups would be very important to understand the altered psychological mechanisms behind psoriasis and to define efficient psychological treatments.
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